Christine Mölzer Selected Research

Gilbert Disease

12/2021	Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals.
9/2021	Oxidative Stress and Related Biomarkers in Gilbert's Syndrome: A Secondary Analysis of Two Case-Control Studies.
1/2021	Gilbert's Syndrome and the Gut Microbiota - Insights From the Case-Control BILIHEALTH Study.
1/2018	Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health.
4/2017	Bilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression.
10/2013	Anti-genotoxic potential of bilirubin in vivo: damage to DNA in hyperbilirubinemic human and animal models.
9/2013	Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Mölzer Research Topics

Disease

7	Gilbert Disease 12/2021 - 09/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 02/2013
3	Uveitis 01/2021 - 01/2020
3	Inflammation (Inflammations) 01/2020 - 09/2013
3	Neoplasms (Cancer) 07/2015 - 02/2013
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 07/2015
2	Fibrosis (Cirrhosis) 01/2019 - 01/2019
2	Obesity 01/2018 - 01/2016
2	Hyperbilirubinemia 04/2017 - 01/2017
1	Dyslipidemias (Dyslipidemia) 12/2021
1	Metabolic Diseases (Metabolic Disease) 12/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Intermediate Uveitis (Chronic Cyclitis) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Posterior Uveitis 01/2020
1	Wounds and Injuries (Trauma) 01/2019
1	Overweight 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015
1	Chronic Disease (Chronic Diseases) 07/2015
1	Disease Resistance 07/2015
1	Noncommunicable Diseases 09/2013

Drug/Important Bio-Agent (IBA)

8	BilirubinIBA 12/2021 - 02/2013
4	Heme (Haem)IBA 01/2021 - 09/2013
2	LipidsIBA 12/2021 - 09/2021
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 07/2015
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2020
2	HydrogelsIBA 01/2019 - 01/2019
2	Bile Pigments (Bilin)IBA 07/2015 - 10/2013
2	TetrapyrrolesIBA 07/2015 - 02/2013
2	DNA (Deoxyribonucleic Acid)IBA 10/2013 - 02/2013
1	Proteins (Proteins, Gene)FDA Link 09/2021
1	Antimutagenic Agents (Antimutagens)IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	interstitial retinol-binding proteinIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	AntigensIBA 01/2020
1	hen egg lysozymeIBA 01/2020
1	N-hydroxysuccinimideIBA 01/2019
1	TenascinIBA 01/2019
1	Keratin-12 (Keratin 12)IBA 01/2019
1	LDL CholesterolIBA 04/2017
1	CholesterolIBA 04/2017
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	Biological ProductsIBA 07/2015
1	AntioxidantsIBA 10/2013
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 09/2013
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	IronIBA 09/2013
1	protoporphyrin IXIBA 02/2013
1	UrobilinIBA 02/2013
1	stercobilinIBA 02/2013